Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 |
|---|---|---|---|---|---|
| 1 | Asthma 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 2 | Asthma 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Cendakimab Cendakimab 💬
| Cendakimab | 098 1件: 98 💬
|
| 3 | Asthma 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 4 | Asthma 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|
| 5 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 6 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Cendakimab Cendakimab 💬
| Cendakimab | 098 1件: 98 💬
|
| 7 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 8 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|
| 9 | Fc epsilon RI signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 10 | Fc epsilon RI signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Cendakimab Cendakimab 💬
| Cendakimab | 098 1件: 98 💬
|
| 11 | Fc epsilon RI signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 12 | Fc epsilon RI signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|
| 13 | IL-17 signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 14 | IL-17 signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Cendakimab Cendakimab 💬
| Cendakimab | 098 1件: 98 💬
|
| 15 | IL-17 signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 16 | IL-17 signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|
| 17 | Inflammatory bowel disease 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 18 | Inflammatory bowel disease 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Cendakimab Cendakimab 💬
| Cendakimab | 098 1件: 98 💬
|
| 19 | Inflammatory bowel disease 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 20 | Inflammatory bowel disease 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|
| 21 | JAK-STAT signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 22 | JAK-STAT signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Cendakimab Cendakimab 💬
| Cendakimab | 098 1件: 98 💬
|
| 23 | JAK-STAT signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 24 | JAK-STAT signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|
| 25 | Pathways in cancer 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 26 | Pathways in cancer 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Cendakimab Cendakimab 💬
| Cendakimab | 098 1件: 98 💬
|
| 27 | Pathways in cancer 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 28 | Pathways in cancer 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|
| 29 | Th1 and Th2 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 30 | Th1 and Th2 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Cendakimab Cendakimab 💬
| Cendakimab | 098 1件: 98 💬
|
| 31 | Th1 and Th2 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 32 | Th1 and Th2 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 3 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|